Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated to revision v3.5.3, replacing v3.5.2, indicating a minor maintenance release for the page. This change does not alter the study content or key information presented on the page.
    Difference
    0.1%
    Check dated 2026-04-30T16:36:52.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2; v3.5.2 was added and v3.5.0 removed. This updates the page version without changing the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-04-16T10:29:53.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.1%
    Check dated 2026-03-25T20:18:35.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:47:53.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2; the previous Revision: v3.4.1 and the government funding lapse notice were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:34:08.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status, and the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:28:04.000Z thumbnail image

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.